Research / ALSN / Fundamental state Inspectable configuration
State dimensions Filing 0000950170-24-086738 General Corporate
Debt relative to revenue 25th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.debt_to_revenue
296.20% · OPTIONAL · VALID
Capex intensity 13th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.57% · OPTIONAL · VALID
Operating cash generation 13th Own-history percentile · N=16
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
20.96% · OPTIONAL · VALID
Revenue growth 8th Own-history percentile · N=12
Evidence method Yoy · gp.fundamentals.revenue
4.21% · CORE · VALID
Inventory pressure 81th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
37.13% · OPTIONAL · VALID
Gross margin 69th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.gross_margin
48.28% · CORE · VALID
Operating margin 100th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.operating_margin
32.23% · CORE · VALID
R&D intensity 19th Own-history percentile · N=16
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
6.00% · OPTIONAL · VALID
SBC intensity 94th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.98% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 25 states Self-history eligible
Sep 30, 2021 0/9 normalized Level 3 Dec 31, 2021 0/9 normalized Level 3 Mar 31, 2022 0/9 normalized Level 3 Jun 30, 2022 8/9 normalized Level 3 Sep 30, 2022 8/9 normalized Level 3 Dec 31, 2022 8/9 normalized Level 3 Mar 31, 2023 8/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 306.46%
Current 296.20%
Delta -10.26% Capex Intensity Increased
Previous 1.39%
Current 2.57%
Delta 1.18% Cash Generation Decreased
Previous 21.93%
Current 20.96%
Delta -0.97% Growth Decreased
Previous 6.48%
Current 4.21%
Delta -2.26% Inventory Pressure Increased
Previous 36.63%
Current 37.13%
Delta 0.50% Margin Increased
Previous 46.39%
Current 48.28%
Delta 1.90% Profitability Increased
Previous 29.66%
Current 32.23%
Delta 2.57% R And D Intensity Increased
Previous 5.83%
Current 6.00%
Delta 0.17% Sbc Intensity Increased
Previous 0.76%
Current 0.98%
Delta 0.22% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.